World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12608000357358
Date of registration: 25/07/2008
Prospective Registration: Yes
Primary sponsor: Professor Colin J Morley
Public title: In extremely low birth weight (ELBW) infants who require positive pressure at birth does the use of a respiratory Function Monitor reduce face mask leak and improve the target tidal volume in the first ten minutes of life?
Scientific title: In extremely low birth weight (ELBW) infants who require positive pressure at birth does the use of a respiratory Function Monitor reduce face mask leak and improve the target tidal volume in the first ten minutes of life?
Date of first enrolment: 11/11/2008
Target sample size: 70
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12608000357358.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase: 
Countries of recruitment
Australia
Contacts
Name: Dr. Georg Schmoelzer   
Address:  Neonatal Services The Royal Women's Hospital, 20 Flemington Road, Parkville, 3052, Vic Australia
Telephone: +61 3 8345 3775
Email: georg.schmoelzer@thewomens.org.au
Affiliation: 
Name: Dr. Georg Schmoelzer   
Address:  Neonatal Services The Royal Women's Hospital, 20 Flemington Road, Parkville, 3052, Vic Australia
Telephone: +61 3 8345 3775
Email: georg.schmoelzer@thewomens.org.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Infants born in the Royal Women's Hospital who need positive pressure ventilation for resuscitation in the delivery room
Exclusion criteria: Infants will be excluded from final analysis if they have a congenital abnormality or condition that might have an adverse effect on breathing or ventilation, including: Congenital Diaphragmatic Hernia. Infants will also be excluded if their parents refuse to give consent to this study.

Age minimum: Days
Age maximum: Days
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Does the use of a respiratory Function Monitor during positive pressure ventilation reduce face mask leak and improve the target tidal volume in the first ten minutes of life?;
Does the use of a respiratory Function Monitor during positive pressure ventilation reduce face mask leak and improve the target tidal volume in the first ten minutes of life?
Reproductive Health and Childbirth - Complications of newborn
Intervention(s)
A randomised controlled trial of a Respiratory Function Monitor during positive pressure ventilation during resuscitation of infants. A flowsensor will be placed between the mask and the Neopuff T-piece-device. This flowsensor measures the airflow and calculates the tidal volume. Each infant requiring positive pressure ventilation at birth will be recorded with the flowsensor in place, the duration of this recording will last during the initial stabilisation in the delivery room.
The duration of the trial is 12 months; we anticipate completing recruitment in October 2009.
Primary Outcome(s)
Reduction of Face mask leak during positive pressure ventilation
The leak is calculated in percentage of inspired tidal volume: leak in percentage= [(inspired tidal volume - expired tidal volume)/inspired tidal volume] * 100.
A t-test for statistical analysis will be performed[when ventilation is no longer required]
Secondary Outcome(s)
Rate of intubation in the delivery room.
During stabilisation in the delivery room the rate of intubation in both groups will be measured. A Chi2 for statistical analysis will be performed[during resuscitation in the delivery room]
Changes in heart rate in the first ten minutes of life
A pulse oximeter will be used to record the heart rate during stabilisation. A Chi2 for statistical analysis will be performed[During the first 10 minutes of life]
Changes in oxygen saturation in the first ten minutes of life
A pulse oximeter will be used to record the oxygen saturation during stabilisation. A Chi2 for statistical analysis will be performed.[During the first 10 minutes of life]
Difference in the delivered tidal volumeThe inspired and the expired tidal volume is measured in both groups. A t-test for statistical analysis will be performed[when ventilation is no longer required]
Days of respiratory support
The total days of respiratory (ventilation, CPAP, oxygen) support during hospital stay will be recorded for each individual baby and both groups will be compared, A Chi2 for statistical analysis will be performed[when ventilation is no longer required]
Days of ventilation
The total days of ventilation support during hospital stay will be recorded for each individual baby and both groups will be compared, A Chi2 for statistical analysis will be performed[when ventilation is no longer required.]
Oxygen treatment at 36 weeks gestational age
If a baby still requires oxygen, CPAP of ventilation. A Chi2 for statistical analysis will be performed[at corrected 36 weeks gestational age]
Secondary ID(s)
NIL
Source(s) of Monetary Support
National Health and Medical Research Council Program Grant
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history